Vladislava V. Khalenko

Dr. Vladislava V. Khalenko

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2025 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
EKEkaterina V. Kopteeva
Ekaterina V. Kopteeva
VKVladislava V. Khalenko
Vladislava V. Khalenko
OPOlga V. Pachuliia
Olga V. Pachuliia
OBOlesya N. Bespalova
Olesya N. Bespalova

29 March 2023 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
OPOlga Pachuliia
Olga Pachuliia
VKVladislava V. Khalenko
Vladislava V. Khalenko
MSMargarita O. Shengeliia
Margarita O. Shengeliia
OBOlesya N. Bespalova
Olesya N. Bespalova
The cervical remodeling process is unique and consists of softening, ripening, dilation at fetal birth, and repair to the original state, which is a dense long tubular structure. In this review, the problem of impaired cervical remodeling is discussed in both preterm birth and delayed transformation, which leads to the unpreparedness of the cervix for childbirth and prolongation of pregnancy. Histological, immunological and structural dynamic changes in the cervix begin long before delivery and are noted as early as the first trimester of gestation. There are a few ways to assess the maturity of the cervix. In the second and third trimester, in order to predict preterm birth, these are ultrasound cervicometry and a cervical phosphorylated insulin-like growth factor binding protein-1 test. At full term, in order to determine its readiness for delivery, this is a palpation assessment. Inadequate assessment of the cervical characteristics is one of the factors of untimely prevention of preterm birth, and at full term leads to inappropriate choice of method of preparation for labor. It is necessary to develop new approaches to the comprehensive assessment of the cervix, using existing methods, and to discover new ways to assess its maturity. In this review, the problem of cervical maturation diagnosis is considered based on literature data from such databases as PubMed, ResearchGate, and Google Scholar, as well as from electronic resources of the M. Gorky Scientific Library (St. Petersburg State University, Russia). This review analyzes data on molecular, biochemical and histophysiological processes occurring during cervical maturation at all stages of gestation. It is generally accepted that the main role in cervical changes at all stages of gestation is played by: collagen fiber restructuring / desorganization, decreased concentrations of collagen and elastin, high molecular weight hylauronic acid cleavage, increased aquaparin level and tissue hydrophilicity, increased cervical vascularization, as well as changes in glycosaminoglycan and matrix metalloproteinase content. Palpatory technique and ultrasound cervicometry are the most common methods of determining the cervical length, which have insufficient sensitivity, probably because they do not cover all pathogenetic pathways of remodeling and cannot assess all cervical characteristics. Improvement of efficiency is possible through the introduction of combined techniques and the use of promising methods such as elastography, ultrasound diagnosis of the cervix with Doppler assessment of its vessels, determination of a disintegrin and metalloprotease with thrombospondin-like repeats-1 and placental 1-microglobulin in cervical secretion, and relaxin in maternal blood. Understanding the molecular, biochemical and histophysiological processes that occur during cervical remodeling is crucial for predicting preterm birth, diagnosing isthmic-cervical insufficiency, understanding the lack of timely cervical readiness, and choosing tactics the method of preinduction and induction of labor if necessary. The lack of clinical methods and their lack of objectivity require a combined approach and the search for new prognostic markers of cervical maturation.

27 May 2024 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
VKVladislava V. Khalenko
Vladislava V. Khalenko
EKEkaterina Kopteeva
Ekaterina Kopteeva
OBOlesya N. Bespalova
Olesya N. Bespalova
OPOlga Pachuliia
Olga Pachuliia
EKEkaterina A. Kornyushina
Ekaterina A. Kornyushina
IKIgor Yu. Kogan
Igor Yu. Kogan
BACKGROUND: Ultrasound assessment of cervical length is an integral part of a comprehensive examination during pregnancy, but it does not provide a complete picture of structural changes in the cervix. The use of E-Cervix elastography is a promising method to assess cervical remodeling throughout the gestation period. AIM: The aim of this study was to evaluate the possibility of using automated cervical elastography in clinical practice to analyze the main parameters of cervical elasticity and hardness in pregnancy. MATERIALS AND METHODS: This prospective pilot study included 136 patients with singleton pregnancies at gestational ages ranging from 7+0 to 41+0 weeks. Cervical elastography was performed using E-Cervix software of the W10 diagnostic ultrasound system (Samsung Medison Co., Ltd., South Korea) with evaluation of quantitative parameters such as hardness ratio, elasticity contrast index, internal os, external os. RESULTS: Correlation analysis showed that hardness ratio decreased with increasing gestational age (ρ = −0.439) and decreasing cervical length (ρ = 0.408; p 0.001). In the group of patients with cervical length less than 25 mm, there was a decrease in hardness ratio compared to the control group (48.0 vs. 63.8%, respectively; p 0.001). The elasticity contrast index score, which reflects cervical tissue heterogeneity, increased with gestational age and cervical shortening (ρ = 0.368 and −0.450, respectively), the parameter being higher in patients with cervical length less than 25 mm [4.73 (IQR 4.21–5.90); p 0.001]. The increase in internal os and external os with gestational age (ρ = 0.433 and ρ = 0.365, respectively; p 0.001) indicates softening of the cervix and is accompanied by its shortening. CONCLUSIONS: Results indicate decreased hardness and increased elasticity of the cervix with increasing gestational age and decreased cervical length. E-Cervix technology allows for assessing structural changes in the cervix throughout pregnancy, starting from early gestation.


Verified
Journal Article
Open access
PDF file
KOKseniia V. Obedkova
Kseniia V. Obedkova
VKVladislava V. Khalenko
Vladislava V. Khalenko
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
JRJulian Ryzhov
Julian Ryzhov
OBOlesya N. Bespalova
Olesya N. Bespalova
NTNatalya I. Tapilskaya
Natalya I. Tapilskaya
Drug delivery systems enhance drug efficacy while minimizing side effects. Liposomes, as well-studied and clinically approved carriers, offer biodegradability, biocompatibility, and low toxicity, making them suitable for delivering various pharmacological agents. Granulocyte colony-stimulating factor (G-CSF), a key growth factor, has shown therapeutic potential, particularly in infertility treatment. It effectively manages chronic and refractory endometritis by improving endometrial receptivity and increasing embryo implantation success. Studies indicate that G-CSF promotes endometrial growth and enhances the uterine microenvironment, benefiting patients with recurrent implantation failures and chronic endometritis. Encapsulation of G-CSF in liposomes enhances its stability, bioavailability, and controlled release. G-CSF-loaded liposomes were prepared using passive loading via the thin-film hydration method. The size of the liposomes, polydispersity index (PDI), and zeta potential were determined using dynamic and electrophoretic light scattering methods, and the encapsulation efficiency was measured using high-performance liquid chromatography. The morphology of the liposomes was established and confirmed using cryogenic transmission electron microscopy. The cytocompatibility of the G-CSF-loaded liposomes was evaluated on human dermal fibroblasts using an MTT assay. The G-CSF-loaded liposomes had an average particle size of 161.9 ± 9.9 nm, a PDI of 0.261 ± 0.03, and a zeta potential of +2.09 ± 0.10 mV, exhibiting high physical stability during long-term storage at +4 °C and 60% humidity. The passive loading method resulted in a 52.37 ± 3.64% encapsulation efficiency of the active substance. The analysis of cell viability revealed no cytotoxicity toward liposomes loaded with G-CSF and demonstrated a dose-dependent effect on the viability of human dermal fibroblasts. Thus, the obtained data confirm the successful preparation of G-CSF-loaded liposomes. However, to fully understand their effectiveness in biomedical applications, further research is needed, including an evaluation of their effectiveness in vivo. Such studies will help in determining the potential of these formulations for specific biomedical purposes and evaluating their safety and efficacy in living systems.

12 November 2025 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
OPO. V. Pachuliya
O. V. Pachuliya
TLTatyana E. Lazareva Lazareva
Tatyana E. Lazareva Lazareva
VKVladislava V. Khalenko
Vladislava V. Khalenko
RIR. A. Illarionov
R. A. Illarionov
EVElena Vashukova
Elena Vashukova
Andrey Sergeevich GlotovAndrey Sergeevich Glotov
Andrey Sergeevich Glotov
Aim: to develop an algorithm for early modeling of preterm birth (PB) high risk using a biocollection of pregnancy samples created according to the "longitudinal biobanking" strategy, based on clinical, proteomic, and transcriptomic data. Materials and Methods . A prospective cohort study was conducted. Serum and plasma samples were retrieved dynamically from a biocollection during the first and second trimesters of gestation from 18 pregnant women with PB high risk developed cervical insufficiency (CI), and from 18 pregnant women with PB low risk not complicated by СI at any stage of gestation. Clinical and anamnestic predictors were analyzed, and serum relaxin and elastin levels, as well as marker microRNAs (hsa-miR-432-5p, hsa-miR-134-5p, hsa-miR-431-5p, hsa-miR-122-5, and hsa-miR-34a-5p) were quantitated. Results. Based on the most significant clinical and anamnestic predictors, a proteomic predictor (serum relaxin level), and transcriptomic predictors (marker microRNAs expression) using a support vector machine (SVM), a predictive model was developed, which high efficiency was confirmed by ROC curves (AUC = 0.83 during training and 0.67 in cross-validation). This allows the developed classifier to be used as a tool for assessing PB risk. Conclusion. Biocollections of pregnant women's samples, formed according to the "longitudinal biobanking" strategy, can serve as an effective platform for developing technologies for early predicted PB risk of obstetric complications.